Press release
Key Trends Influencing the Growth of the Coronary Stents Market in 2025: Innovative Advancements In Coronary Stents
Coronary Stents Market
What Is the Expected CAGR for the Coronary Stents Market Through 2025?
There has been a consistent upward trend in the size of the coronary stents market in the past few years. This market is projected to increase from $11.06 billion in 2024 to $12.02 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.6%. The factors contributing to the growth during the historical period include a rising inclination towards minimally invasive procedures, broader healthcare access in emerging markets, augmented healthcare spending, an upsurge in percutaneous coronary interventions, and an increase in the number of practicing cardiologists.
What's the Projected Size of the Global Coronary Stents Market by 2029?
The market for coronary stents is anticipated to experience a significant surge in its size in the upcoming years, with projections reaching $16.5 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.3%. This expansion during the predicted period is mainly due to the increased prevalence of cardiovascular ailments, an aging demographic, heightened awareness regarding cardiac health, supportive initiatives and funding from governments, and a rising occurrence of lifestyle diseases. The forecast period will also see key trends such as stent technology advancements, innovations in imaging technologies, strategic alliances and partnerships, improvements in stent materials, and the merging of technology with digital health.
View the full report here:
https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report
Top Growth Drivers in the Coronary Stents Industry: What's Accelerating the Market?
The ongoing increase in cardiovascular diseases (CVDs) is anticipated to stimulate the expansion of the coronary stent market. These disorders, affecting the heart and blood vessels, include conditions like coronary artery disease, heart failure, stroke and hypertension. Factors such as an aging population, escalating incipient conditions like obesity, diabetes, sedentary habits, poor nutrition and stress contribute to the rise of CVDs. A coronary stent is essential for treating these diseases by enlarging constricted or obstructed coronary arteries, enhancing blood circulation to the heart, and diminishing the threat of heart attacks. For instance, a report in August 2022 by the American College of Cardiology, a non-profit medical association based in the US, forecast considerable increases in cardiovascular risk factors in the US from 2025 to 2060. A predicted rise of 39.3% to 55 million people in diabetes cases, dyslipidemia increasing by 27.6% to 126 million, hypertension expanding by 25.1% to 162 million, and obesity growing by 18.3% to 126 million, are alarming. The largest projected increases in CVDs include stroke (33.8% increase, amounting to 15 million) and heart failure (33.4% increase to 13 million), followed by ischemic heart disease (30.7% increase to 29 million) and heart attacks (16.9% increase to 16 million). Thus, the escalating prevalence of CVDs is fuelling the expansion of the coronary stent market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp
What Trends Will Shape the Coronary Stents Market Through 2029 and Beyond?
Significant corporations functioning in the coronary stent industry are strategizing by creating unique products like drug-eluting stents, which decrease the necessity for subsequent procedures when compared to conventional bare-metal stents. Essentially, drug-eluting stents are distinctive coronary stents layered with a particular medicine developed to obstruct arterial re-narrowing by steadily releasing drugs over a period. For instance, in May 2024, Abbott, a healthcare company based in the US, introduced the XIENCE Sierra Everolimus (medicinal) Eluting Coronary Stent System in India. The XIENCE Sierra stent is impressive due to its superior architecture, innovative delivery system, and exclusive size alternatives, specifically made for complex situations. This stent maintains the specialized coating that mitigates the chance of arterial re-blocking, which is a feature consistent with other similar XIENCE stent products. More than 120 clinical trials involving over 120,000 patients stand as proof of the stent's remarkable safety profile.
What Are the Main Segments in the Coronary Stents Market?
The coronary stents market covered in this report is segmented -
1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents
2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies
3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum-Chromium, Nickel-Titanium, Polymer
4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents
5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
Subsegments:
1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents
2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents
3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents
4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents
5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents
6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents
7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents
8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents
9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp
Which Top Companies are Driving Growth in the Coronary Stents Market?
Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation
Which Regions Will Dominate the Coronary Stents Market Through 2029?
North America was the largest region in the coronary stents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18325
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trends Influencing the Growth of the Coronary Stents Market in 2025: Innovative Advancements In Coronary Stents here
News-ID: 4132519 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Stent
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
